Fixed combination of oral NEPA (netupitant‐palonosetron) for the prevention of acute and delayed chemotherapy‐induced nausea and vomiting in patients receiving multiple cycles of c...

por Schwartzberg, Lee, Karthaus, Meinolf, Rossi, Giorgia, Rizzi, Giada, Borroni, Maria E., Rugo, Hope S., Jordan, Karin, Hansen, Vincent
Publicado 2019

Efficacy and safety of oral palonosetron compared with IV palonosetron administered with dexamethasone for the prevention of chemotherapy-induced nausea and vomiting (CINV) in pati...

por Karthaus, Meinolf, Tibor, Csőszi, Lorusso, Vito, Singh-Arora, Rajender, Filippov, Alexander, Rizzi, Giada, Borroni, Maria Elisa, Rossi, Giorgia, Grunberg, Steven M.
Publicado 2015

NEPA, a fixed oral combination of netupitant and palonosetron, improves control of chemotherapy-induced nausea and vomiting (CINV) over multiple cycles of chemotherapy: results of...

por Aapro, Matti, Karthaus, Meinolf, Schwartzberg, Lee, Bondarenko, Igor, Sarosiek, Tomasz, Oprean, Cristina, Cardona-Huerta, Servando, Hansen, Vincent, Rossi, Giorgia, Rizzi, Giada, Borroni, Maria Elisa, Rugo, Hope
Publicado 2016

Phase IIIb Safety and Efficacy of Intravenous NEPA for Prevention of Chemotherapy‐Induced Nausea and Vomiting (CINV) in Patients with Breast Cancer Receiving Initial and Repeat Cyc...

por Schwartzberg, Lee, Navari, Rudolph, Clark‐Snow, Rebecca, Arkania, Ekaterine, Radyukova, Irena, Patel, Kamal, Voisin, Daniel, Rizzi, Giada, Wickham, Rita, Gralla, Richard J., Aapro, Matti, Roeland, Eric
Publicado 2019